Oct 1 |
Phio Pharmaceuticals Announces Upcoming Presentation at ASGCT's 2024 Advancing Gene + Cell Therapies for Cancer Conference
|
Sep 25 |
INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society
|
Sep 16 |
Phio Pharmaceuticals Announces Presentation at the 9th Annual CAR-TCR Summit in Boston, MA
|
Sep 9 |
Phio Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
Aug 29 |
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
|
Aug 27 |
Phio Pharmaceuticals Corp.'s (NASDAQ:PHIO) Path To Profitability
|
Aug 15 |
Phio Pharmaceuticals GAAP EPS of -$3.62 beats by $0.52
|
Aug 14 |
Phio Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
|
Aug 6 |
Phio Pharmaceuticals Announces Exploratory Collaboration with a Luxury Skin Care Company for Phio's Patented INTASYL Compound
|
Aug 1 |
Phio Pharmaceuticals appoints Robert Infarinato as chief financial officer
|